Skip to main content

Antiviral Pill Lowers Risks of COVID-19 Hospitalization, Death


via The Scientist RSS https://ift.tt/3A5jZCq Merck reports that its antiviral molnupiravir was effective against early stages of COVID-19 in high-risk patients in a Phase 3 clinical trial. https://ift.tt/eA8V8J October 02, 2021 at 01:10AM
Labels:

Comments

Post a Comment

Popular posts from this blog

Doubts Raised Over Whether Mice Can Truly Inherit Immunity

via The Scientist RSS https://ift.tt/3fXmHT5 An independent lab fails to replicate results suggesting mammals exposed to pathogens could pass on immunological protections through epigenetic mechanisms. https://ift.tt/eA8V8J January 27, 2022 at 12:10AM
Post a Comment
Read more

A New Smartphone Application Improves Memory Recall in Older Adults

via The Scientist RSS https://ift.tt/HF8yhqs Neuroscientists developed and tested a promising mobile app that mitigates age-related memory decline. https://ift.tt/kpa8Dct May 08, 2023 at 11:26PM
Post a Comment
Read more

Alu Leap May Explain Why Apes Don't Have Tails

via The Scientist RSS https://ift.tt/3u3quo5 A transposable element that jumped into the TBXT gene, which is linked to tail morphology, appears to be to blame for our missing appendage. https://ift.tt/eA8V8J September 23, 2021 at 06:28PM
Post a Comment
Read more